Rossari Biotech is currently trading at Rs. 859.00, up by 13.25 points or 1.57% from its previous closing of Rs. 845.75 on the BSE.
The scrip opened at Rs. 849.00 and has touched a high and low of Rs. 868.85 and Rs. 849.00 respectively. So far 4072 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 966.00 on 23-Sep-2024 and a 52 week low of Rs. 657.80 on 05-Jun-2024.
Last one week high and low of the scrip stood at Rs. 911.00 and Rs. 822.75 respectively. The current market cap of the company is Rs. 4760.13 crore.
The promoters holding in the company stood at 68.32%, while Institutions and Non-Institutions held 20.70% and 10.98% respectively.
Rossari Biotech’s wholly owned subsidiary--- Rossari Global DMCC has incorporated a step down wholly owned subsidiary in the name of ‘Rossari Biotech Trading FZE’ on October 07, 2024 vide the order of Registrar of Jebel Ali Free Zone (JAFZA) received on October 08, 2024.
The step-down subsidiary incorporated in JAFZA will primarily focus on trading and manufacturing activities including handling of distribution and sales of chemicals and consumer products for export markets.
Rossari Biotech is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products.
| Company Name | CMP |
|---|---|
| BASF India | 3660.00 |
| Tata Chemicals | 822.40 |
| SRF | 2641.00 |
| Pidilite Inds. | 1406.00 |
| Deepak Nitrite | 1768.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: